THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION INC (EIN 752816066) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1999

Legal Domicile

Principal Officer

DARCIENA ANDERSON CHRISTE

Phone

8773636376

Tax Period

2023-01-01 to 2023-12-31

THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION INC, founded in 1999, is a community nonprofit in the Diseases & Disorders sector that reported $1.5M in total revenue in fiscal year 2023. Revenue decreased 9% compared to the prior year. Net assets of $9.4M represent 73 months of operating reserves.

Mission

TO OFFER HOPE AND SUPPORT TO MESOTHELIOMA CANCER PATIENTS AND THEIR FAMILIES THROUGH EDUCATION, FUNDING OF QUALITY, PEER-REVIEWED RESEARCH, AND RAISE PUBLIC AWARENESS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $944,461

Program Service Revenue $476,947

Investment Income $122,229

Other Revenue $3,232

TOTAL REVENUE $1,546,869

Expense Breakdown

Grants Paid $472,278

Salaries & Benefits $633,760

Fundraising Expenses $145,890

Program Expenses $1,124,403

Other Expenses $426,185

TOTAL EXPENSES $1,532,223

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,546,869	$1,693,216	-0.1%
Expenses	$1,532,223	$1,190,526	+0.3%
Net Income	$14,646	$502,690	-1.0%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$266,983

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MARJORIE G ZAUDERER MD MS FACP	CHAIR	1.00	Officer Director	$0	$0	$0
DARCIENA ANDERSON CHRISTEL	TREASURER	1.00	Officer Director	$0	$0	$0
R TAYLOR RIPLEY MD	SECRETARY	1.00	Officer Director	$0	$0	$0
KEITH CENGEL MD PHD	DIRECTOR	1.00	Director	$0	$0	$0
JASON M FOSTER MD	DIRECTOR	1.00	Director	$0	$0	$0
AARON S MANSFIELD MD	DIRECTOR	1.00	Director	$0	$0	$0
SANJAY POPAT PHD	DIRECTOR	1.00	Director	$0	$0	$0
BORIS SEPESI MD	DIRECTOR	1.00	Director	$0	$0	$0
DANIEL STERMAN MD	DIRECTOR	1.00	Director	$0	$0	$0
JAMES STEVENSON MD	DIRECTOR	1.00	Director	$0	$0	$0
WILLIAM N ZIEGLER	DIRECTOR	1.00	Director	$0	$0	$0
CHERYL BRUNER ESQ	DIRECTOR	1.00	Director	$0	$0	$0
JESSICA BLACKFORD-CLEETON	DIRECTOR	1.00	Director	$0	$0	$0
JULIE POWERS	EXECUTIVE DIRECTOR	40.00	Officer	$120,056	$5,670	$125,726
MAJA BELAMARIC	COO	40.00	Officer	$134,162	$7,095	$141,257

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,546,869	$1,532,223	$9,971,454	$14,646
2022	$1,693,216	$1,190,526	$9,449,879	$502,690
2021	$3,031,525	$1,257,170	$9,384,474	$1,774,355
2020	$5,570,526	$1,070,432	$7,513,333	$4,500,094
2019	$2,084,465	$1,230,873	$2,806,619	$853,592
2018	$1,269,294	$1,480,319	$1,950,261	$-211,025

THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION INC